戻る Agenda
[V1-S2] Recent Trend of Pharmaceutical Regulation in the World
Session Chair(s)
Guido Rasi, MD
Chairman,Clinical Trial Center of Gemelli Polyclinic Inst; Prof of Microbiology, Tor Vergata University of Rome, Italy
Jens Piero Quartarolo, MD, MBA, MSC
Director of Division for Pharmacovigilance & Medical Devices, Danish Medicines Agency, Denmark
To respond to issues such as innovative technologies, globalization, and the increased awareness about drug safety among the general public, regulators around the world are introducing or revising existing regulation/legislations. In this session, executives from leading regulatory agencies will introduce the latest regulatory trends, as well as cooperation among agencies (e.g. ICH) and other topics.
Speaker(s)
Agnès Saint-Raymond, DrMed
Head of Division International Affairs, European Medicines Agency, Netherlands
Recent Trend of Pharmaceutical Regulation in Europe
Rong Sun, PHD
Associate Director with the Centre for Evaluation of Radiopharmaceuticals and Bi, Health Canada, Canada
Recent Trend of Pharmaceutical Regulation in Americas
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Recent Trend of Pharmaceutical Regulation in Asia
Alison Cossar
Manager, Product Regulation Branch, Medsafe, Ministry of Health, NZ, New Zealand
Recent Trend of Pharmaceutical Regulation in Oseania
John Graham, PHD, MBA
Director, Office of Research Center for Veterinary Medicine, FDA, United States
Rita Purcell, LLM
Deputy Chief Executive, Health Products Regulatory Authority (HPRA), Ireland